This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rudin, C M Articles by Storb, U Search for Related Content PubMed PubMed Citation Articles by Rudin, C M Articles by Storb, U

 Previous Article  |  Next Article 

Mol Cell Biol. 1992 January; 12(1): 309-320

Two conserved essential motifs of the murine immunoglobulin lambda enhancers bind B-cell-specific factors.

Department of Molecular Genetics and Cell Biology, University of Chicago, Illinois 60637.

ABSTRACT

Two highly homologous enhancers associated with the two murine immunoglobulin lambda constant-region clusters were recently identified. In order to better understand the molecular basis for the developmental stage- and cell-type-restricted expression of lambda genes, we have undertaken an analysis of the putative regulatory domains of these enhancers. By using a combination of DNase I footprinting, electrophoretic mobility shift assay, and site-specific mutations, four candidate protein binding sites have been identified at analogous positions in both enhancers. A mutation of any of these sites decreases enhancer activity. Two of the sites, lambda A and lambda B, are essential for enhancer function, and both of these sites appear to bind both B-cell-specific and general factors. Nevertheless, isolated lambda A and lambda B sites show no evidence of inherent transactivating potential, alone or together, even when present in up to three copies. We suggest that the generation of transactivating signals from these enhancers may require the complex interaction of multiple B-cell-specific and nonspecific DNA-binding factors.

This article has been cited by other articles:

• Combriato, G., Klobeck, H.-G. (2002). Regulation of Human Ig{lambda} Light Chain Gene Expression by NF-{kappa}B. J. Immunol. 168: 1259-1266 [Abstract] [Full Text]  
• Satyaraj, E., Storb, U. (1998). Mef2 Proteins, Required for Muscle Differentiation, Bind an Essential Site in the Ig {lambda} Enhancer. J. Immunol. 161: 4795-4802 [Abstract] [Full Text]  
• Young, H. A., Klinman, D. M., Reynolds, D. A., Grzegorzewski, K. J., Nii, A., Ward, J. M., Winkler-Pickett, R. T., Ortaldo, J. R., Kenny, J. J., Komschlies, K. L. (1997). Bone Marrow and Thymus Expression of Interferon-gamma Results in Severe B-Cell Lineage Reduction, T-Cell Lineage Alterations, and Hematopoietic Progenitor Deficiencies. Blood 89: 583-595 [Abstract] [Full Text]  
• Eisenbeis, C F, Singh, H, Storb, U (1995). Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator.. Genes Dev. 9: 1377-1387 [Abstract]